VivoSeq
Other

Dexamethasone Administration

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Dexamethasone Administration is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

13/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

8

clinical trials

Completed5 · 63%
Recruiting2 · 25%
Withdrawn1 · 13%

Clinical Trials

Trial Activity

8 trials

The Effect of Dexamethasone Administration Route in Pediatric Brachial Plexus Block
Recruiting·PPoznan University of Medical Sciences·Phase 4·NCT07061678·90 enrolled
Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty
Recruiting·—·Phase 4·NCT04507412·74 enrolled
The Effect of Dexamethasone Administration Route in PENG Block for Pediatric Hip Surgery
Completed·PPoznan University of Medical Sciences·Phase 4·NCT06789367·60 enrolled
Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role?
Completed·TThe Cleveland Clinic·Phase 2·NCT03338400·51 enrolled
The Effect of Perioperative Dexamethasone Administration on Postoperative Pain in Patients Undergoing Periacetabular Osteotomy.
Completed·OOdense University Hospital·Phase 2/3·NCT03874936·90 enrolled
The Optimal Time of IV Dexamethasone Administration for Prolongation of Peripheral Nerve Block
Completed·UUniversity Health Network, Toronto·Phase 4·NCT03394820·197 enrolled
Influence of Intrathecal Dexamethasone Administration for Proximal Femoral Fractures
Completed·GGeneral Hospital Sveti Duh·N/A·NCT03856502·60 enrolled
Does Dexamethasone Administration Improve Recovery In Patients Undergoing Minimally Invasive Sacrocolpopexy?
Withdrawn·TThe Cleveland Clinic·N/A·NCT03094442

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)